• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 CRAGG-MCNAMARA; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 CRAGG-MCNAMARA; CATHETER, CONTINUOUS FLUSH Back to Search Results
Model Number UNK-NV-CRAGG-MC
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Septic Shock (2068); Respiratory Failure (2484)
Event Date 04/19/2016
Event Type  Death  
Manufacturer Narrative
Silverberg d, menes t, rimon u, salomon o, halak m.Acute renal artery occlusion: presentation, treatment, and outcome.Journal of vascular surgery.2016;64(4):1026-1032.Doi:10.1016/j.Jvs.2016.04.043.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Silverberg d, menes t, rimon u, salomon o, halak m.Acute renal artery occlusion: presentation, treatment, and outcome.Journal of vascular surgery.2016;64(4):1026-1032.Doi:10.1016/j.Jvs.2016.04.043.Medtronic literature review found a report of patient complications in association with a cragg-mcnamara infusion catheter.The purpose of this article was to identify patients with acute kidney infarction; to characterize their presentation, imaging, and treatment; and to compare the subgroup of patients who underwent catheter-directed thrombolysis (cdt) with those who were treated without intervention.Thirteen patients were treated with cdt, which involved the use of the cragg-mcnamara catheter.Of the 13 patients, 11 were male and the average age was 59 years.All cdt patients completed the treatment, and no major complications occurred during the course of the thrombolytic therapy.The article does not state any technical issues during use of the cragg-mcnamara catheter.The following intra- or post-procedural outcomes were noted: - in-house mortality occurred in one patient in the cdt group.The patient underwent unsuccessful thrombolytic therapy of a transplanted kidney, developed respiratory failure, and died of septic shock.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CRAGG-MCNAMARA
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key14046135
MDR Text Key288821645
Report Number2029214-2022-00596
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeIS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-NV-CRAGG-MC
Device Catalogue NumberUNK-NV-CRAGG-MC
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/06/2022
Initial Date FDA Received04/07/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age59 YR
Patient SexMale
-
-